DR. BARUAH HEART CITY

                                                                                                   

                                                                             CITY OF HUMAN GENOME A INSITUTE OF APPLIED HUMAN GENETIC ENGINEERINGCITY OF HUMAN GENOME A INSITUTE OF APPLIED HUMAN GENETIC ENGINEERINGCITY OF HUMAN GENOME A INSITUTE OF APPLIED HUMAN GENETIC ENGINEERINGCITY OF HUMAN GENOME A INSITUTE OF APPLIED HUMAN GENETIC ENGINEERINGCITY OF HUMAN GENOME A INSITUTE OF APPLIED HUMAN GENETIC ENGINEERINGCITY OF HUMAN GENOME A INSITUTE OF APPLIED HUMAN GENETIC ENGINEERINGCITY OF HUMAN GENOME A INSITUTE OF APPLIED HUMAN GENETIC ENGINEERINGCITY OF HUMAN GENOME A INSITUTE OF APPLIED HUMAN GENETIC ENGINEERING                          &

           A CITY OF KNOWLEDGE NOT MADE OF BRICKS & MORTAR

Home I C.V. of Dr. dhaniram Baruah I Patient, FDA & Publications I Pre - & Post - TreatmentDoppler Studies Case Report I My Achievements & Significant evidences
 
 Most Popular Categories

Unlimited poweR     of                  GenetiC EngineerinG

Inventor’s mouth.

Consequences of my research.

Introduction.

Mysteries in genetic sciences.

What is coronary artery disease?

Misconceptions in cardio-vascular sciences.

Foundation on which building of Baruah Applied Human.

Revolution in medical sciences rocked by Dr.D.R. Baruah,FRCSGlas.

Unfolding the mysteries in human genetic sciences.

Mysteries in human genetic sciences.

How does the mutation expresses in particular disease form?

Selection of patients for gene analysis

Eradication of heart disease & rarest of the rare diseases- Human genetic studies through sequencing of m-RNA.

Signal Transduction plays a major role during pre-bypass and post-bypass events.

How bypass surgery triggers signal transduction & phenotypically expressed.

Mutation

Selection of genes causing heart & other diseases.

Hypoxia, reactive oxygen species, intracellular calcium & Baruah syndrome.

Re-sequencing of the following genes to identify the mysteries.

First time on this planet– Genovac.

Baruah applied human genetic engineering- a choice of treatment for Cancer.

TGA-A New Method of Treatment of Complex Congenital Heart Disease.

Endocardial Cushion defect.

Genetic Engineering–To cure the rarest of the rare autoimmune.

First time on the Planet–Manifestation of Baruah Syndrome–Moyamoya

The rarest of the rare genetic disorder–Takayasu.

Isolated congenital Right Ventricular Hypertrophy.

---------------------------------------        -----------------------

Applied Human Genetic Engineering - Vol.II

UNFOLDING THE MYSTERIES OF GENETIC SCIENCES IN INCURABLE DISEASES LIKE CORONARY ARTERY DISEASES, CANCER, & RAREST OF THE RARE DISEASES LIKE MOYAMOYA, SLE, TAKAYASU ETC.

CITY OF HUMAN GENOME A INSITUTE OF APPLIED HUMAN GENETIC ENGINEERING

              

The rarest of the rare genetic disordeR

Takayasu & My new discoveries Mitral valve disease is another form of takayasu - not of rheumatic origin is cured permanently with Application of Baruah Applied Human Genetic engineering

Takayasu, the rarest of the rare disorder is found in average of two cases in one million of population.

 Introduction-

          Dr. Mikito Takayasu was Japanese ophthalmologist, who described this disease in 1908, found a young man of 36 who came to him with sudden blurred vision. During investigation, he found that his retinal arteries were inflamed and blood supply to retina was insufficient and subsequent investigation revealed that the patient had pulseless wrist and feet. The cause of disease was not known at that time. Subsequently, there were many patients treated by other doctors with anti-inflammatory drugs like cortisone, and immunosuppressive drugs like Cyclophosphamide., but success was not recorded.

 What is Vasculitis?

         Our circulatory system is made of network of blood vessels, including veins, arteries and capillaries. If all of our blood vessels were joined end to end, they would extend the length of nearly 60,000 miles. Arteries deliver oxygen-rich blood to our body’s tissues, while veins return blood with increased amounts of carbon dioxide — a waste product of metabolism — to our heart and ultimately to lungs for purification.

          In vasculitis, the blood vessels become inflamed, which can cause the layers of the blood vessel wall thickened. This narrows the lumen of blood vessels, reducing the amount of forward blood flow— and thereby reduces oxygen and vital nutrients — that reaches to tissues. In some cases, a blood clot may form in an affected blood vessel, obstructing blood flow. Sometimes instead of becoming narrower, a blood vessel may weaken and form a bulge (aneurysm).

          What is Takayasu’s arteritis?- It is a chronic inflammatory condition that affects the largest blood vessel in the body (the aorta) and its branches. Thus, the complications of Takayasu’s arise directly or indirectly from damage to these blood vessels. The vasculitides are classified according to the size of blood vessel involved. Takayasu’s is one type of classic "large vessel" vasculitis.

 My contribution-

             Dr. Takaysu’s description and findings were strictly confined to inflammation of arteries only. However, our research work has suggested it is not true as it is a syndrome involving entire circulatory system where veins are also involved leading to reduction of inflow of blood to right heart and ultimate left heart suffers leading to inadequate left ventricular filling and causes death.

            In heart valve disease like mitral valve which is the commonest valve to be affected is due to vasculitis or arteritis, although, it was thought till now that this is the valvular disease caused by streptococcus. We have found many cases of mitral and aortic valve disease, where there is no history of rheumatic valve disease, where streptococcal infection to be blamed. This has been proven by curing these valvular diseases with Baruah genetic engineering by using Baruah biological molecules, therefore, we found that mitral or aortic valve replacement is not always the answer to cure valvular disease. The requirement of replacement of heart valve is wrong diagnosis and treatment.

            We have treated 55 cases of mitral incompetence and stenosis, 15 cases of aortic incompetence and stenosis. 65% of mitral valve disease had history of rheumatic fever and 100% aortic valve disease had no history of rheumatic fever. These patients were in long wait list of heart valve surgery. They were all treated by Baruah genetic engineering during the period of last 12 months.

            Pathological findings and overexpression of genes.

           Histological findings reveals that cell-mediated immunity plays an important role in the pathogenetic sequence leading to vascular lesions. The cause of the disease is unknown. Histological findings of inflammatory cell infiltration and necrosis of the arterial vascular cells strongly suggest that cell-mediated immunity plays an important role in the pathogenetic sequence leading to the lesions.

         In Takayasu arteritis, inflammatory cell infiltration tends to be localized in the adventitia and outer part of lymphocytes, natural killer (NK) cells, macrophages, cytotoxic T lymphocytes, and T helper cells. Natural killer cells, may recognize a 65-kD heat-shock protein expressed in the aortic tissue and induce vascular cell injury by releasing the cytolytic factor perforin.

        Elevated plasma levels of interleukin (IL)-6 and increased expression of IL-6 and IL-1ß in both circulating mononuclear cells and tissue-infiltrating macrophages have been observed in patients with giant-cell arteritis. IL-1ß and IL-6 are proinflammatory cytokines synthesized mainly by activated monocytes, macrophages, and T cells. These cytokines have overlapping activities such as B- and T-cell activation, fibroblast proliferation, and acute-phase protein synthesis. IL-1ß induces a large number of cytokines and upregulates the expression of adhesion molecules on endothelial cells, thus promoting leukocyte interactions with the endothelium ; IL-6 enhances T-cell cytotoxicity and natural killer cell activity.

        Baruah biological molecules reduces inflammatory activity by controlling interleukin activity. physiological correction is achieved and patient becomes asymptomatic.

          In case of hypertrophy of the ventricles either left or right, more systolic and diastolic pressure is exerted because of the increased rigidity of collagen protein and rigidity disappears. Due to mutation of this particular gene, when metabolic process is reversed, rigidity of the collagen protein disappeared and behaviour of the ventricles become physiological, so functionally, myocardium is working normal, with achievement of disappearance of symptoms and thereby, mental and physical growth of the child becomes normal. These patients when they are usually breathless and cyanosed on exertion and they do not do well in the school.

 How Baruah Genetic engineering work in valvular disease ?

             By injecting Baruah biological molecules, the m-RNA are overexpressed which engineers the diseased genes with following effects:-

      1 It reduces the inflammation of smallest capillaries and arteries and ultimately disappears. Thereby, forward blood flow increases, adequate oxygenation is given at subcellular level, allows synthesize required amount of ATP, resulting increase and improved strength of collagen bundles, reduces fibrosis and ultimately valve becomes competent with improved motions of the valve leaflet.

     In valvular disease, myocardium is usually stretched and it loses its ejection power. Once, ATP is adequately synthesized and valves began to be competent with disappearance of fibrosis and calcification, ejection power of myocardium become improved and increased and already dilated myocardium reduces its size and bring it to normal and heart as a whole functions physiological.

           We have discovered in 5 cases not having arteritis, but their entire venous system is inflamed and inflow of venous blood was reduced in certain parts and completely blocked in certain parts particularly in legs. They have got swelling of legs and arms with tachycardia , tiredness. Tachycardia was due to inadequate ventricular filling.

Case no.1:-   33 year old man attended our clinic with swelling of entire body with legs, particularly both legs and arms. The swelling was not pitting and it was almost solidified. We attempted several times to take his venous blood from his both arms and legs, but failed. We wanted to treat the patient with genetic engineering, but his parents refused to go ahead with the treatment and further follow up was not possible.

Case 2- Man of 26years suffered from painful legs and swelling with breathlessness. He was treated in CMCH, Vellore. But no diagnosis was made. His treatment was symptomatic. One year later, he attended our clinic and diagnosis was made as inflammation of veins of legs and arms including subclavian and innominate. He was suffering from tachycardia due to insufficient ventricular filling. Colour Doppler flow studies have suggested that his arterial flow was normal and his entire venous system was inflamed and inflow of blood flow to right heart was inadequate He had skin discoloration (blackishness). He was treated with Baruah biological molecules to engineer his m-RNA expressed diseased genes and after 72 hours later, swelling of legs and arm began to reduce and his tiredness and pain on walking were reduced. Repeat colour Doppler flow studies have suggested that his venous inflow was adequate. His tachycardia was disappeared His skin discolouration disappeared. There was no skin ulcer. He was discharged. Post- discharged period was uneventful.

Case 3- A man of 68years, retired government official, non-smoker and non-alcoholic had suffered from multiple ulcerative skin lesions., not responded to dermatological treatment.. He was having swelling of legs, arms and entire body as a whole. He was treated by dermatologist for one year with no remedy. He attended our clinic six month ago with complains of multiple itchy ulcers. His right cuff was more painful than left during walking. Colour Doppler flow studies have suggested that there was reduction of forward arterial blood flow, more in right common femoral along with venous inflow of both right and left subclavian veins was reduced.

        After genetic engineering with Baruah biological molecules and his skin ulcers were healed and he became a normal man.

  Arteritis- Treated with Baruah genetic engineering

         A women of 33 years old had suffered from pain in both legs, and dizziness. Her pulse in both wrists was not detectable, her blodd pressure was not recordable. Both anterial tibial arteries having absence pulsation. She was investigated and diagnosed elsewhere. Diagnosis was made on the basis of the findings of peripheral angiography. Complete blockages were reported in vertebral arteries and partial blockages in common carotid arteries, which was making her dizzy. Both subclavian arteries were blocked completely and so is the femoral arteries. Muscles were functioning on collateral circulation. Genetic engineering was performed using Baruah biological molecules. Her pulsation of radial and anterior tibial arteries were palpable after 96 hours of the treatment. Her chest pain disappeared and she remain, femoral and dexcending aortans symptomless. (A 33 years old housewife totally incapacitated with Takayasu of arterial origin, suffered from severe dizziness, pain and cramps in the legs. No pulsation in popleteal and radial arteries, entire arterial system was partially blocked. Now she is asymptomatic since last 5 years and de-aged by 20 years.)

           A 42 years old house wife had suffered from severe pain during walking. Her tolerance was upto 10 yards. She was breathlessness and tired with chest pain.Colour Doppler flow studies revealed multiple blockages in both subclavian, femoral, descending aorta. After genetic engineering using Baruah biological molecules, her all symptoms disappeared. Now she is healthy leading normal life since last one year.

           In conclusion, takayasu is not strictly confined to to arteritis what was described by Dr.Takayasu in the past. It affects veins and heart valve as well. There was no treatment for takasu in the past and now it is been treated successfully with Baruah genetic engineering by use of Baruah biological molecules as tools.

  Pathological findings and overexpression of genes.

         Histological findings reveals that cell-mediated immunity plays an important role in the pathogenetic sequence leading to vascular lesions. The cause of the disease is unknown. Histological findings of inflammatory cell infiltration and necrosis of the arterial vascular cells strongly suggest that cell-mediated immunity plays an important role in the pathogenetic sequence leading to the lesions.

       In Takayasu arteritis, inflammatory cell infiltration tends to be localized in the adventitia and outer part of lymphocytes, natural killer (NK) cells, macrophages, cytotoxic T lymphocytes, and T helper cells. Natural killer cells, may recognize a 65-kD heat-shock protein expressed in the aortic tissue and induce vascular cell injury by releasing the cytolytic factor perforin.

      Elevated plasma levels of interleukin (IL)-6 and increased expression of IL-6 and IL-1ß in both circulating mononuclear cells and tissue-infiltrating macrophages have been observed in patients with giant-cell arteritis. IL-1ß and IL-6 are proinflammatory cytokines synthesized mainly by activated monocytes, macrophages, and T cells. These cytokines have overlapping activities such as B- and T-cell activation, fibroblast proliferation, and acute-phase protein synthesis. IL-1ß induces a large number of cytokines and upregulates the expression of adhesion molecules on endothelial cells, thus promoting leukocyte interactions with the endothelium ; IL-6 enhances T-cell cytotoxicity and natural killer cell activity.

         Baruah biological molecules reduces inflammatory activity by controlling interleukin activity, thereby, physiological correction is achieved and patient becomes asymptomatic.

         In case of hypertrophy of the ventricles either left or right, more systolic and diastolic pressure is exerted because of the increased rigidity of collagen protein and rigidity disappears. Due to mutation of this particular gene, when metabolic process is reversed, rigidity of the collagen protein disappeared and behaviour of the ventricles become physiological, so functionally, myocardium is working normal, with achievement of disappearance of symptoms and thereby, mental and physical growth of the child becomes normal. These patients when they are usually breathless and cyanosed on exertion and they do not do well in the school.

Copyright© DR Dhani Ram Baruah  Heart City2007 Best view in 1024 by 768 pixels